Regulatory Compliance in the Pharmaceutical Supply Chain

Event Information
Product Format
Prerecorded Event
Presenter(s)
Length
90 Minutes
Product Description

Understand How to Restructure the Company’s Supply Chain in Pharmaceutical Industry and Learn the Regulatory Compliance Associated with it

The U.S. Food and Drug Administration (FDA) launched a major initiative to modernize the regulation of drug manufacturing and product quality in 2002. This program calls for the application of modern risk and quality management techniques, the use of engineering knowledge and new manufacturing technologies, and the application and demonstration of cutting-edge science throughout the entire production process.

Driven by the increase in the number of adverse events and drug recalls in recent years, FDA has changed its method of monitoring drug manufacturing. They introduced systems thinking, quality by design and related processes that assure the quality of any product in manufacturing. This resulted in a new FDA initiative 'Good Manufacturing Practices (GMP's) for the 21st century'. The initiative requires pharmaceutical companies to comprehensively manage patient risk, base new drug submissions and manufacturing approaches on demonstrable scientific principles, and simultaneously implement inspection-ready 'GMP Systems' which embed compliance and quality in their operations. Of particular significance, is the risk transfer among products which result from the new approach of GMP Systems inspections. All products produced at a facility may be considered 'adulterated' if any one GMP system fails inspection. It is possible that a single low-revenue high-risk product may wipe out an entire facility's revenue. The assets and infrastructure of pharmaceutical companies were designed to meet the 25-year old GMP regulations and are now exposed to the new risks brought up by the FDA programs related to quality by design.


One of the practical implications of the FDA's challenge is the restructuring of a company's supply chain. A company will need to manage its risks across products, technologies, and sites, and ensure that its drugs are safe at the point-of-use. This conference by expert speaker Angela Bazigos will show the participant how to best achieve this to avoid adverse inspection results or harm to patients. The conference will also discuss the current cGMP requirements for the pharmaceutical supply chain and explain how to best implement them for successful inspections, and how to ensure that issues are addressed in a way that patient safety and good inspection results are preserved.

Training Objective:

  • What is the pharmaceutical supply chain?
  • What are the cGMPs (regulatory requirements)?
  • Latest FDA (and international) initiatives for Regulatory Compliance
  • How are they implemented using a risk based model?
  • How can they be streamlined for production optimization while preserving patient safety?
  • How are they inspected both domestically and internationally?
  • What are the risks that can impact compliance and inspections?
  • How to plan ahead to mitigate those risks or to address them in a way that avoids adverse inspection results?

Who Should Attend

  • Design engineers / managers / senior managers
  • Manufacturing engineers / managers / senior managers
  • Operations managers
  • Purchasing
  • Quality Control / managers / senior managers
  • Quality Assurance / managers / senior managers
  • Document control managers
  • IT / managers / senior managers
  • Lean project managers

 

Order Below or Call 1-866-458-2965 Today

Order Form

(Select the format below)

Choose Quantity:

(*) Single User Price

You can also order through:
Phone

1-866-458-2965

Fax

1-919-287-2643

About Our Speaker

Angela Bazigos - Pharma Conferences

Angela Bazigos is the CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers & Public Health Services companies. Positions include Chief Compliance Officer at Morf Media, Director of QA,...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus